Life Sciences
In the rapidly-evolving landscape of drug discovery and development, traditional approaches to R&D in biopharma are no longer sufficient. Artificial intelligence (AI) continues to be a game-changer.
Read More
R&D leaders and scientists need a working understanding of key AI concepts so they can more effectively develop future-forward data strategies and lead the charge towards groundbreaking discoveries.
Read More
Scattered and siloed data is one of the top challenges slowing down scientific discovery and innovation today. What every R&D organization needs is a data fabric as part of their technology solution set.
Read More
With the increasing importance of AI and machine learning in science and engineering, it is critical that the leadership of R&D and IT groups at innovative companies are aligned. Inappropriate budgeting, policies, or vendor choices can unnecessarily block critical research programs; conversely an “anything goes” approach can squander valuable resources or leave an organization open to novel security threats.
Read More
OpenAI’s ChatGPT, Google’s Bard, and other similar Large Language Models (LLMs) have made dramatic strides in their ability to interact with people using natural language. Users can describe what they want done and have the LLM “understand” and respond appropriately.
Read More
Mammalian cell culture is a fundamental tool for many discoveries, innovations, and products in the life sciences.
Read More
In the digital era, robust data tools are crucial for all companies and the science-driven industries like the life sciences, materials science, and chemistry are no exception.
Read More
As a company that delivers Digital Transformation for Science, part of our job at Enthought is to understand the trends that will affect how our clients do their science. Below are three trends that caught our attention in 2022 that we predict will take center stage in 2023. ChatGPT This one just showed up on…
Read MoreEnthought’s team in Japan exhibited at the Pharma IT & Digital Health Expo 2022 life sciences conference in Tokyo, to meet with pharmaceutical industry leaders gathering for technological insight and to revitalize market growth. 200 companies exhibited across the 3-day in-person event, which drew over 6,700 attendees. With digital transformation a headline theme, the show…
Read More
Labs are resetting the trajectory for drug development: reducing timelines from years to months; decreasing costs from billions to millions; and gaining an advantage by delivering drugs to market in months rather than decades. This value combination is a compelling case for investment in digital capability and organizational transformation. A 100x or 1000x advance in…
Read More